Here's Why I Wouldn't Touch Moderna With a 10‑Foot Pole Until Its Next Growth Engine Is Clear

Moderna made a fortune with COVID vaccines, but revenue has since declined.

Moderna’s vaccine ambitions run into a wall of ‘anti-science’ scepticism

Pfizer’s Albert Bourla put it more bluntly in Davos last month, saying it’s a “different world when you start discussing ...